Lilly’s weight loss drug reduces diabetes risk in overweight patients
Eli Lilly’s weight-loss drug Zepbound dramatically reduces the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the drug’s maker said Tuesday.
BELIEBTE BEITRÄGE
Colombia was the deadliest country for environmentalists in 2023
September 11, 2024
Floods inundate northern Vietnam, Typhoon Yagi death toll rises
September 11, 2024
Destin Daniel Cretton in talks to direct ‘Spider-Man 4’
September 11, 2024
LIVEÜBERTRAGUNG